BME Seminar - Wed., Feb. 5 - CHANGE of speaker
|Event Date:||February 5, 2014|
|Hosted By:||Weldon School of BME
|Location:||MJIS 1001, WL campus
Abstract: Circulating tumor cells (or CTCs) are a type of extremely rare cells that are derived from primary tumors and enter into blood circulation. It has been shown that CTC count in blood correlates with the overall tumor burden. In addition, CTCs' genetic content can be analyzed to reveal mutations that led to the cancer in question. Since they can be obtained by a minimally invasive blood draw, they are promising candidates to become the 'liquid biopsy,' and allow frequent monitoring of the disease, assess the patients response to therapy, and minimize the amount of invasive and distressing tests. This talk will present a new system developed here at Purdue that can analyze clinically relevant amounts of blood samples to find rare cells with near 90% efficiency. Preliminary tests performed on lung cancer patients' blood samples indicate that CTC count could differ between patients that have received treatment and those that have not.
Bio: Cagri Savran received his BS from Purdue in 1998, MS and PhD from MIT in 2000 and 2004; all degrees being in mechanical engineering. He has been a faculty member of the School of Mechanical Engineering with a courtesy appointment in Weldon School of Biomedical Engineering since 2004. His research focuses on development of novel platforms for biological detection with a special emphasis on robust and high-throughput sensors for cancer detection.
~BME Faculty Host: Sherry Voytik-Harbin~
***Coffee and juice will be provided at West Lafayette***